B-LYMPHOCYTE ANTIGEN CD20
UNII TB2Q79LBS0

Substance Identification & Data

This profile provides standardized clinical and technical data for B-lymphocyte Antigen Cd20, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TB2Q79LBS0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TB2Q79LBS0

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

B-LYMPHOCYTE ANTIGEN CD20

Official standardized name for this substance within the FDA UNII nomenclature system.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for B-lymphocyte Antigen Cd20. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.